AN2 Therapeutics, Inc. Insider Transactions
AN2 Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Easom Eric
CEO |
Buy | 10,000 @ $1.07 | $10.67 K | 256,380 | 06/02/2025 | 06/03/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 425,000 @ $1.01 | $429.25 K | 3,224,432 | 05/30/2025 | 05/30/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 7,000 @ $1.03 | $7.23 K | 3,217,432 | 05/30/2025 | 05/30/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 2,000,000 @ $1.16 | $2.32 M | 3,749,432 | 05/28/2025 | 05/30/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 100,000 @ $1.16 | $116.00 K | 3,649,432 | 05/28/2025 | 05/30/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 200,000 @ $1.09 | $218.00 K | 3,017,432 | 05/28/2025 | 06/16/2025 | |
|
FitzPatrick Margaret M
Director |
Buy | 8,610 @ $1.18 | $10.13 K | 8,610 | 05/28/2025 | 05/29/2025 | |
|
Eizen Joshua M
See Remarks |
Sell | 9,663 @ $1.34 | $12.96 K | 116,672 | 01/03/2025 | 01/07/2025 | |
|
Day Lucy
CFO |
Sell | 2,957 @ $1.34 | $3.97 K | 32,670 | 01/03/2025 | 01/07/2025 | |
|
Chanda Sanjay
Chief Development Officer |
Sell | 2,957 @ $1.34 | $3.97 K | 29,824 | 01/03/2025 | 01/07/2025 | |
|
Prior Stephen David
Chief Strategy Officer |
Sell | 2,029 @ $1.34 | $2.72 K | 33,313 | 01/03/2025 | 01/07/2025 | |
|
Readnour Robin Shane
Director |
Buy | 5,000 @ $1.49 | $7.46 K | 582,288 | 12/10/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 18,483 @ $1.43 | $26.41 K | 647,573 | 12/09/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 12,289 @ $1.43 | $17.58 K | 577,288 | 12/09/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 12,711 @ $1.45 | $18.37 K | 564,999 | 12/06/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 6,517 @ $1.45 | $9.43 K | 629,090 | 12/06/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 25,000 @ $1.42 | $35.42 K | 622,573 | 11/27/2024 | 11/27/2024 | |
|
Zakrzewski Joseph S
Director |
Buy | 2,000 @ $1.40 | $2.80 K | 125,199 | 11/27/2024 | 11/27/2024 | |
|
Readnour Robin Shane
Director |
Buy | 12,500 @ $1.39 | $17.43 K | 597,573 | 11/26/2024 | 11/27/2024 | |
|
Readnour Robin Shane
Director |
Buy | 25,000 @ $1.16 | $29.00 K | 585,073 | 11/20/2024 | 11/21/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AN2 Therapeutics, Inc. FAQ's
The list of insiders at AN2 Therapeutics, Inc. includes RA CAPITAL MANAGEMENT, L.P., Leonard Braden Michael, Zakrzewski Joseph S, Easom Eric, Readnour Robin Shane, Day Lucy, Chanda Sanjay, Prior Stephen David, Eizen Joshua M, FitzPatrick Margaret M.
Insiders have sold a total of 6.27 M AN2 Therapeutics, Inc. shares in the last 12 months for a total of 6.92 M sold.
The following insiders have sold AN2 Therapeutics, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($3.81 M), Day Lucy ($3.97 K), Chanda Sanjay ($3.97 K), Prior Stephen David ($2.72 K), Eizen Joshua M ($12.96 K), Leonard Braden Michael ($3.09 M),
Insiders have purchased a total of 1.79 M AN2 Therapeutics, Inc. shares in the last 12 months for a total of 1.90 M.
The following insiders have purchased AN2 Therapeutics, Inc. shares in the last 12 months: Leonard Braden Michael ($1.56 M), Zakrzewski Joseph S ($27.85 K), Easom Eric ($60.64 K), Readnour Robin Shane ($238.61 K), FitzPatrick Margaret M ($10.13 K),